Publication of Suppl.Prospcts
Summary by AI BETAClose X
31 October 2025
SMITHS GROUP PLC
PUBLICATION OF SUPPLEMENT TO BASE PROSPECTUS
The following supplement to a base prospectus has been approved by the UK Financial Conduct Authority and is available for viewing:
Supplement dated 31 October 2025 (the "Supplement") to the Base Prospectus dated 17 April 2025 (the "Base Prospectus") relating to the EUR 2,500,000,000 Euro Medium Term Note Programme of Smiths Group plc guaranteed by Smiths Group International Holdings Limited.
Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.
To view the full document, please paste the following URL into the address bar of your browser:
https://data.fca.org.uk/artefacts/NSM/Portal/NI-000132628/NI-000132628.pdf
A copy of the Supplement has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Investor Enquiries
Siobhán Andrews, Smiths Group
+44 (0)7920 230093
siobhan.andrews@smiths.com
Ana Pita da Veiga, Smiths Group
+44 (0)7386 689442
Media Enquiries
Tom Steiner, Smiths Group
+44 (0)7787 415 891
Company Secretary
Matthew Whyte
+44 (0) 7775 982 879
Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11
About Smiths Group
For over 170 years, we have been pioneers of progress, engineering a better future. Our strategy is to be a focused, efficient and value creating industrial engineering company operating in the attractive and growing market segments of energy, industrials and construction. We focus on solving the toughest problems for our customers, helping address critical global needs such as decarbonisation and the ever-increasing demand for process and energy efficiency. Listed on the London Stock Exchange, we employ c.16,000 colleagues in over 50 countries. For more, visit www.smiths.com.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplement and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus as supplemented by the Supplement is not addressed. Prior to relying on the information contained in the Supplement or the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein. By accessing this document, you will be deemed to certify that you are located outside the United States and are not accessing the Supplement or the Base Prospectus from a location inside the United States.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Johnson Matthey
- 3 hours ago Galliford Try
- 3 hours ago Galliford Try
- 3 hours ago Centrica
- 4 hours ago Smith & Nephew